Archive - March 2021
Merck & Co, Ridgeback Biotherapeutics’ COVID-19 drug shows early promise
Gilead’s HIV therapy Biktarvy demonstrates long-term sustained efficacy
CHMP issues positive opinion for Lilly’s COVID-19 antibodies
Radiotherapy responses may be improved with targeted immunotherapy, study suggests
NHS England agrees deal with Novartis for access to SMA gene therapy Zolgensma
Lifting Covid restrictions Too Soon? Data Say Maybe
The Long Haul for Long Covid Patients
GCI Health opens new office in Brussels